InvestorsHub Logo

H2R

Followers 42
Posts 2157
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: Rymankoly post# 4300

Monday, 10/23/2017 8:03:34 AM

Monday, October 23, 2017 8:03:34 AM

Post# of 4817

Treatment was well tolerated
3 SAEs were reported but not considered drug related by investigators



The safety concerns did not seem like much in this presentation:
http://www.smsna.org/scottsdale2016/presentations/131.pdf

Strange the FDA comes up with safety concerns now.